XML 42 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 11 - Warrants
3 Months Ended
Mar. 31, 2013
Warrants [Text Block]
Note 11. Warrants

Common Stock Warrants

Following is a summary of all warrant activity for the first three months of 2013:

Warrants
 
Number of Warrants Issued
   
Weighted Average Exercise Price
 
Warrants outstanding at December 31, 2012
    7,863,653     $ 3.37  
                 
Warrants granted in connection with the Preferred Stock Offering as more fully described in Note 9
    6,036,219     $ 1.18  
                 
Warrants exercised for common stock
    (71,250 )     3.25  
                 
Warrants outstanding at March 31, 2013
    13,828,622     $ 2.42  
                 
Aggregate intrinsic value of outstanding warrants at March 31, 2013
  $          
                 
Weighted average remaining contractual terms (years)
    4.23          

During the first quarter of 2013, the Company received gross proceeds of approximately $0.2 million from the exercise of warrants to purchase 71,250 shares of common stock.

Common Stock Warrant Liability

In September 2009, the Company closed a registered direct offering with a select group of institutional investors that raised gross proceeds of $7.1 million and net proceeds of $6.3 million.  In connection with this registered direct offering, the Company issued 2,018,153 shares of its common stock and warrants to purchase 1,009,076 shares of common stock. The warrants have an exercise price of $5.24 per share and are exercisable at any time on or after the six month anniversary of the date of issuance and on or prior to 66 months after the date of issuance.  Under the terms of the warrants, upon certain transactions, including a merger, tender offer or sale of all or substantially all of the assets of the Company, each warrant holder may elect to receive a cash payment in exchange for the warrant, in an amount determined by application of the Black-Scholes option valuation model. Accordingly, pursuant to ASC 815.40, Derivative Instruments and Hedging - Contracts in Entity’s Own Equity, the warrants are recorded as a liability and then marked to market each period through the Statement of Operations in other income or expense. At the end of each subsequent quarter, the Company will revalue the fair value of the warrants and the change in fair value will be recorded as a change to the warrant liability and the difference will be recorded through the Statement of Operations in other income or expense.

The fair value of the warrants at March 31, 2013 and December 31, 2012 was $3,635 and $4,283,932, respectively, calculated using the Black-Scholes option-pricing model with the following assumptions:

   
March 31, 2013
   
December 31, 2012
 
Risk-free interest rate
   
0.77
%
   
0.73
%
Expected volatility
   
65.8
%
   
92.0
%
Expected life (in years)
   
1.00
     
1.13
 
Expected forfeiture rate
   
0.0
%
   
0.0
%
Expected dividend yield
   
0.00
%
   
0.00
%

As a result of this change in the warrant liability, the Company recorded a non-cash benefit of $4.3 million in the three months ended March 31, 2013. The following is a summary of the changes in the common stock warrant liability for the three months ended March 31, 2013:

Beginning balance as of January 1, 2013
 
$
4,283,932
 
Issuances
   
-
 
Gain from the adjustment for the change in fair value included in net income
   
(4,280,297
Ending balance as of March 31, 2013
 
$
3,635